scholarly journals Combination of waveforms in modern spinal cord stimulation

Author(s):  
Piedade G. S ◽  
Gillner S. ◽  
Slotty P. J. ◽  
Vesper J

Abstract Background After the surge of burst stimulation, different waveforms were developed to optimize results in spinal cord stimulation. Studies have shown higher responder rates for multiwave therapy, but since the launch of such multiwave systems, little is known about the patients’ preference regarding waveforms in the long-term follow-up. No study connected particular waveforms to specific pain etiologies or required stimulation parameters so far. Method Thirty-four patients with refractory chronic neuropathic pain were treated with spinal cord stimulation systems providing multiwave therapy between September 2018 and October 2019. Patients with a follow-up of at least 6 months were selected; 10 subjects were excluded due to revision surgery, infection, and loss to follow-up. Data regarding pain intensity and preferred waveform for the trial, the implantation, 3-month and 6-month follow-up were recorded. Results During the trial phase, 10 patients (43.5%) achieved significant pain relief using tonic stimulation, 5 using burst (21.7%), 3 using microburst (13.0%), and 4 using a combination of tonic and microburst (17.4%). One single patient preferred Contour stimulation during the trial. After 3 months, 6 patients preferred microburst (25%), 6 preferred tonic (25%), 5 used a combination of tonic and microburst (20.8%), and 5 patients used burst (20.8%). After 6 months, similar results were obtained. Contour and Whisper were used in complex cases failing to other waveforms. Conclusions Tonic stimulation, isolated or in combination, remains an important component in spinal cord stimulation, being used by almost half of the patients. Over time, the usage of microburst increased considerably. Whisper and Contour, although battery-consuming, are good salvage options in complex cases.

2013 ◽  
Vol 16 (6) ◽  
pp. 523-529 ◽  
Author(s):  
José W. Geurts ◽  
Helwin Smits ◽  
Marius A. Kemler ◽  
Florian Brunner ◽  
Alfons G. H. Kessels ◽  
...  

2013 ◽  
Vol 37 (4) ◽  
pp. 380-388 ◽  
Author(s):  
Anthony F. DiMarco ◽  
Krzysztof E. Kowalski ◽  
Dana R. Hromyak ◽  
Robert T. Geertman

Heart ◽  
2007 ◽  
Vol 93 (5) ◽  
pp. 591-597 ◽  
Author(s):  
G. Angelo Sgueglia ◽  
A. Sestito ◽  
A. Spinelli ◽  
B. Cioni ◽  
F. Infusino ◽  
...  

Author(s):  
Dennis Møgeltoft Poulsen ◽  
Jens Christian Hedemann Sørensen ◽  
Morten Rune Blichfeldt-Eckhardt ◽  
Helga Angela Gulisano ◽  
Anne Lene Høst Knudsen ◽  
...  

2020 ◽  
Vol 10 (5) ◽  
pp. 319-329
Author(s):  
Ganesan Baranidharan ◽  
Beatrice Bretherton ◽  
Thomas Kay ◽  
Nathan Marsh ◽  
Charlotte Romanis ◽  
...  

Background:Visceral pain can be disabling for patients and challenging to treat in the clinic. Spinal cord stimulation is a NICE approved treatment for chronic neuropathic pain, presenting potential advantages over conventional therapies for managing chronic visceral pain. Results: A retrospective study revealed that a specific type of spinal cord stimulation, BurstDRTM (Abbott, TX, USA), was effective at improving pain and quality of life in patients with chronic visceral pain. Baseline pain scores significantly correlated with change at follow-up, suggesting it may be possible to identify potential responders from the outset. BurstDR was safe: rates of revision, explantation and complications were low. Conclusion: Clinical trials exploring the long-term effects of BurstDR including a control arm are needed. Findings could have the potential to inform best practice and improve outcomes for individuals with chronic visceral pain.


2016 ◽  
Vol 263 (11) ◽  
pp. 2224-2228 ◽  
Author(s):  
Christian Blahak ◽  
Tamara Sauer ◽  
Hansjoerg Baezner ◽  
Marc E. Wolf ◽  
Assel Saryyeva ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document